retatrutide obesity trial results Weight loss with as compared to currently licenced When the Breakthrough Obesity G-Agonist
Description
More on how we write and source these pieces: Editorial process and contributor disclosure and Sourcing posture
Reframe the product portfolio toward function
The study also observed reductions in hospitalizations for MACE among highly adherent GLP-1 users
Safety and efficacy have not been established in children and adolescents under 18 years
GLP-1 medications can reduce saliva production, which makes it easier for bacteria to grow and cause dental problems
What does the clinical evidence say about GLP-1 drugs and sleep
